Global Biobanking Sample Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Biobanking Sample market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Biobanking Sample is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Biobanking Sample is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Biobanking Sample market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Biobanking Sample is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Biobanking Sample market include Becton, Dickinson and Company (US), Biokryo GmbH (Germany), Brooks Automation (US), Chart Industries (US), Greiner Bio One [Greiner Holding AG, Austria)], Hamilton Company (US), LVL Technologies GmbH & Co. KG (Germany), Micronic (Netherlands) and Panasonic Healthcare Holdings Co. Ltd (Japan), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biobanking Sample, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Biobanking Sample, also provides the sales of main regions and countries. Of the upcoming market potential for Biobanking Sample, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biobanking Sample sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Biobanking Sample market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Biobanking Sample sales, projected growth trends, production technology, application and end-user industry.

Biobanking Sample Segment by Company

Becton, Dickinson and Company (US)
Biokryo GmbH (Germany)
Brooks Automation (US)
Chart Industries (US)
Greiner Bio One [Greiner Holding AG, Austria)]
Hamilton Company (US)
LVL Technologies GmbH & Co. KG (Germany)
Micronic (Netherlands)
Panasonic Healthcare Holdings Co. Ltd (Japan)
Promega Corporation (US)
Qiagen N.V. (Germany)
Tecan Group Ltd. (Switzerland)
TTP Labtech Ltd (U.K.)
VWR Corporation (US)
Worthington Industries [(Taylor Wharton, US)]
Merck KGaA (Germany)
Thermo Fisher Scientific Inc(US)

Biobanking Sample Segment by Type

Nucleic Acids
Human Waste Products
Human Tissues
Biological Fluids
Cell Lines
Blood Products

Biobanking Sample Segment by Application

Clinical Research
Life Science Research
Regenerative Medicine

Biobanking Sample Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Biobanking Sample status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Biobanking Sample market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biobanking Sample significant trends, drivers, influence factors in global and regions.
6. To analyze Biobanking Sample competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking Sample market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking Sample and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking Sample.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biobanking Sample market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biobanking Sample industry.
Chapter 3: Detailed analysis of Biobanking Sample manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Biobanking Sample in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Biobanking Sample in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Biobanking Sample Sales Value (2020-2031)
1.2.2 Global Biobanking Sample Sales Volume (2020-2031)
1.2.3 Global Biobanking Sample Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Biobanking Sample Market Dynamics
2.1 Biobanking Sample Industry Trends
2.2 Biobanking Sample Industry Drivers
2.3 Biobanking Sample Industry Opportunities and Challenges
2.4 Biobanking Sample Industry Restraints
3 Biobanking Sample Market by Company
3.1 Global Biobanking Sample Company Revenue Ranking in 2024
3.2 Global Biobanking Sample Revenue by Company (2020-2025)
3.3 Global Biobanking Sample Sales Volume by Company (2020-2025)
3.4 Global Biobanking Sample Average Price by Company (2020-2025)
3.5 Global Biobanking Sample Company Ranking (2023-2025)
3.6 Global Biobanking Sample Company Manufacturing Base and Headquarters
3.7 Global Biobanking Sample Company Product Type and Application
3.8 Global Biobanking Sample Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Biobanking Sample Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Biobanking Sample Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Biobanking Sample Market by Type
4.1 Biobanking Sample Type Introduction
4.1.1 Nucleic Acids
4.1.2 Human Waste Products
4.1.3 Human Tissues
4.1.4 Biological Fluids
4.1.5 Cell Lines
4.1.6 Blood Products
4.2 Global Biobanking Sample Sales Volume by Type
4.2.1 Global Biobanking Sample Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Biobanking Sample Sales Volume by Type (2020-2031)
4.2.3 Global Biobanking Sample Sales Volume Share by Type (2020-2031)
4.3 Global Biobanking Sample Sales Value by Type
4.3.1 Global Biobanking Sample Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Biobanking Sample Sales Value by Type (2020-2031)
4.3.3 Global Biobanking Sample Sales Value Share by Type (2020-2031)
5 Biobanking Sample Market by Application
5.1 Biobanking Sample Application Introduction
5.1.1 Clinical Research
5.1.2 Life Science Research
5.1.3 Regenerative Medicine
5.2 Global Biobanking Sample Sales Volume by Application
5.2.1 Global Biobanking Sample Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Biobanking Sample Sales Volume by Application (2020-2031)
5.2.3 Global Biobanking Sample Sales Volume Share by Application (2020-2031)
5.3 Global Biobanking Sample Sales Value by Application
5.3.1 Global Biobanking Sample Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Biobanking Sample Sales Value by Application (2020-2031)
5.3.3 Global Biobanking Sample Sales Value Share by Application (2020-2031)
6 Biobanking Sample Regional Sales and Value Analysis
6.1 Global Biobanking Sample Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Biobanking Sample Sales by Region (2020-2031)
6.2.1 Global Biobanking Sample Sales by Region: 2020-2025
6.2.2 Global Biobanking Sample Sales by Region (2026-2031)
6.3 Global Biobanking Sample Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Biobanking Sample Sales Value by Region (2020-2031)
6.4.1 Global Biobanking Sample Sales Value by Region: 2020-2025
6.4.2 Global Biobanking Sample Sales Value by Region (2026-2031)
6.5 Global Biobanking Sample Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Biobanking Sample Sales Value (2020-2031)
6.6.2 North America Biobanking Sample Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Biobanking Sample Sales Value (2020-2031)
6.7.2 Europe Biobanking Sample Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Biobanking Sample Sales Value (2020-2031)
6.8.2 Asia-Pacific Biobanking Sample Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Biobanking Sample Sales Value (2020-2031)
6.9.2 South America Biobanking Sample Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Biobanking Sample Sales Value (2020-2031)
6.10.2 Middle East & Africa Biobanking Sample Sales Value Share by Country, 2024 VS 2031
7 Biobanking Sample Country-level Sales and Value Analysis
7.1 Global Biobanking Sample Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Biobanking Sample Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Biobanking Sample Sales by Country (2020-2031)
7.3.1 Global Biobanking Sample Sales by Country (2020-2025)
7.3.2 Global Biobanking Sample Sales by Country (2026-2031)
7.4 Global Biobanking Sample Sales Value by Country (2020-2031)
7.4.1 Global Biobanking Sample Sales Value by Country (2020-2025)
7.4.2 Global Biobanking Sample Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Biobanking Sample Sales Value Growth Rate (2020-2031)
7.5.2 USA Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Biobanking Sample Sales Value Growth Rate (2020-2031)
7.6.2 Canada Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Biobanking Sample Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Biobanking Sample Sales Value Growth Rate (2020-2031)
7.8.2 Germany Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Biobanking Sample Sales Value Growth Rate (2020-2031)
7.9.2 France Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.9.3 France Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Biobanking Sample Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Biobanking Sample Sales Value Growth Rate (2020-2031)
7.11.2 Italy Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Biobanking Sample Sales Value Growth Rate (2020-2031)
7.12.2 Spain Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Biobanking Sample Sales Value Growth Rate (2020-2031)
7.13.2 Russia Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Biobanking Sample Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Biobanking Sample Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Biobanking Sample Sales Value Growth Rate (2020-2031)
7.16.2 China Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.16.3 China Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Biobanking Sample Sales Value Growth Rate (2020-2031)
7.17.2 Japan Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Biobanking Sample Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Biobanking Sample Sales Value Growth Rate (2020-2031)
7.19.2 India Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.19.3 India Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Biobanking Sample Sales Value Growth Rate (2020-2031)
7.20.2 Australia Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Biobanking Sample Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Biobanking Sample Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Biobanking Sample Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Biobanking Sample Sales Value Growth Rate (2020-2031)
7.24.2 Chile Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Biobanking Sample Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Biobanking Sample Sales Value Growth Rate (2020-2031)
7.26.2 Peru Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Biobanking Sample Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Biobanking Sample Sales Value Growth Rate (2020-2031)
7.28.2 Israel Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Biobanking Sample Sales Value Growth Rate (2020-2031)
7.29.2 UAE Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Biobanking Sample Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Biobanking Sample Sales Value Growth Rate (2020-2031)
7.31.2 Iran Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Biobanking Sample Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Biobanking Sample Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Biobanking Sample Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Biobanking Sample Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Becton, Dickinson and Company (US)
8.1.1 Becton, Dickinson and Company (US) Comapny Information
8.1.2 Becton, Dickinson and Company (US) Business Overview
8.1.3 Becton, Dickinson and Company (US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.1.4 Becton, Dickinson and Company (US) Biobanking Sample Product Portfolio
8.1.5 Becton, Dickinson and Company (US) Recent Developments
8.2 Biokryo GmbH (Germany)
8.2.1 Biokryo GmbH (Germany) Comapny Information
8.2.2 Biokryo GmbH (Germany) Business Overview
8.2.3 Biokryo GmbH (Germany) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.2.4 Biokryo GmbH (Germany) Biobanking Sample Product Portfolio
8.2.5 Biokryo GmbH (Germany) Recent Developments
8.3 Brooks Automation (US)
8.3.1 Brooks Automation (US) Comapny Information
8.3.2 Brooks Automation (US) Business Overview
8.3.3 Brooks Automation (US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.3.4 Brooks Automation (US) Biobanking Sample Product Portfolio
8.3.5 Brooks Automation (US) Recent Developments
8.4 Chart Industries (US)
8.4.1 Chart Industries (US) Comapny Information
8.4.2 Chart Industries (US) Business Overview
8.4.3 Chart Industries (US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.4.4 Chart Industries (US) Biobanking Sample Product Portfolio
8.4.5 Chart Industries (US) Recent Developments
8.5 Greiner Bio One [Greiner Holding AG, Austria)]
8.5.1 Greiner Bio One [Greiner Holding AG, Austria)] Comapny Information
8.5.2 Greiner Bio One [Greiner Holding AG, Austria)] Business Overview
8.5.3 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.5.4 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Product Portfolio
8.5.5 Greiner Bio One [Greiner Holding AG, Austria)] Recent Developments
8.6 Hamilton Company (US)
8.6.1 Hamilton Company (US) Comapny Information
8.6.2 Hamilton Company (US) Business Overview
8.6.3 Hamilton Company (US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.6.4 Hamilton Company (US) Biobanking Sample Product Portfolio
8.6.5 Hamilton Company (US) Recent Developments
8.7 LVL Technologies GmbH & Co. KG (Germany)
8.7.1 LVL Technologies GmbH & Co. KG (Germany) Comapny Information
8.7.2 LVL Technologies GmbH & Co. KG (Germany) Business Overview
8.7.3 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.7.4 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Product Portfolio
8.7.5 LVL Technologies GmbH & Co. KG (Germany) Recent Developments
8.8 Micronic (Netherlands)
8.8.1 Micronic (Netherlands) Comapny Information
8.8.2 Micronic (Netherlands) Business Overview
8.8.3 Micronic (Netherlands) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.8.4 Micronic (Netherlands) Biobanking Sample Product Portfolio
8.8.5 Micronic (Netherlands) Recent Developments
8.9 Panasonic Healthcare Holdings Co. Ltd (Japan)
8.9.1 Panasonic Healthcare Holdings Co. Ltd (Japan) Comapny Information
8.9.2 Panasonic Healthcare Holdings Co. Ltd (Japan) Business Overview
8.9.3 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.9.4 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Product Portfolio
8.9.5 Panasonic Healthcare Holdings Co. Ltd (Japan) Recent Developments
8.10 Promega Corporation (US)
8.10.1 Promega Corporation (US) Comapny Information
8.10.2 Promega Corporation (US) Business Overview
8.10.3 Promega Corporation (US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.10.4 Promega Corporation (US) Biobanking Sample Product Portfolio
8.10.5 Promega Corporation (US) Recent Developments
8.11 Qiagen N.V. (Germany)
8.11.1 Qiagen N.V. (Germany) Comapny Information
8.11.2 Qiagen N.V. (Germany) Business Overview
8.11.3 Qiagen N.V. (Germany) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.11.4 Qiagen N.V. (Germany) Biobanking Sample Product Portfolio
8.11.5 Qiagen N.V. (Germany) Recent Developments
8.12 Tecan Group Ltd. (Switzerland)
8.12.1 Tecan Group Ltd. (Switzerland) Comapny Information
8.12.2 Tecan Group Ltd. (Switzerland) Business Overview
8.12.3 Tecan Group Ltd. (Switzerland) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.12.4 Tecan Group Ltd. (Switzerland) Biobanking Sample Product Portfolio
8.12.5 Tecan Group Ltd. (Switzerland) Recent Developments
8.13 TTP Labtech Ltd (U.K.)
8.13.1 TTP Labtech Ltd (U.K.) Comapny Information
8.13.2 TTP Labtech Ltd (U.K.) Business Overview
8.13.3 TTP Labtech Ltd (U.K.) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.13.4 TTP Labtech Ltd (U.K.) Biobanking Sample Product Portfolio
8.13.5 TTP Labtech Ltd (U.K.) Recent Developments
8.14 VWR Corporation (US)
8.14.1 VWR Corporation (US) Comapny Information
8.14.2 VWR Corporation (US) Business Overview
8.14.3 VWR Corporation (US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.14.4 VWR Corporation (US) Biobanking Sample Product Portfolio
8.14.5 VWR Corporation (US) Recent Developments
8.15 Worthington Industries [(Taylor Wharton, US)]
8.15.1 Worthington Industries [(Taylor Wharton, US)] Comapny Information
8.15.2 Worthington Industries [(Taylor Wharton, US)] Business Overview
8.15.3 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.15.4 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Product Portfolio
8.15.5 Worthington Industries [(Taylor Wharton, US)] Recent Developments
8.16 Merck KGaA (Germany)
8.16.1 Merck KGaA (Germany) Comapny Information
8.16.2 Merck KGaA (Germany) Business Overview
8.16.3 Merck KGaA (Germany) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.16.4 Merck KGaA (Germany) Biobanking Sample Product Portfolio
8.16.5 Merck KGaA (Germany) Recent Developments
8.17 Thermo Fisher Scientific Inc(US)
8.17.1 Thermo Fisher Scientific Inc(US) Comapny Information
8.17.2 Thermo Fisher Scientific Inc(US) Business Overview
8.17.3 Thermo Fisher Scientific Inc(US) Biobanking Sample Sales, Value and Gross Margin (2020-2025)
8.17.4 Thermo Fisher Scientific Inc(US) Biobanking Sample Product Portfolio
8.17.5 Thermo Fisher Scientific Inc(US) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Biobanking Sample Value Chain Analysis
9.1.1 Biobanking Sample Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Biobanking Sample Sales Mode & Process
9.2 Biobanking Sample Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Biobanking Sample Distributors
9.2.3 Biobanking Sample Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings